RET and medullary thyroid gland carcinoma: Moreover, while somatic RET mutations are generally considered negative prognostic indicators, some studies argue that these mutations do not necessarily correlate with compromised disease-specific survival (DSS) or overall survival (OS) in patients with MTC [254].